annual shareholders equity:
-$49.19M-$18.60M(-60.82%)Summary
- As of today (September 15, 2025), AKBA annual stockholders equity is -$49.19 million, with the most recent change of -$18.60 million (-60.82%) on December 31, 2024.
- During the last 3 years, AKBA annual shareholders equity has fallen by -$123.19 million (-166.46%).
- AKBA annual shareholders equity is now -107.73% below its all-time high of $635.93 million, reached on December 31, 2018.
Performance
AKBA Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$29.22M+$4.64M(+18.89%)Summary
- As of today (September 15, 2025), AKBA quarterly stockholders equity is $29.22 million, with the most recent change of +$4.64 million (+18.89%) on June 1, 2025.
- Over the past year, AKBA quarterly shareholders equity has increased by +$62.98 million (+186.58%).
- AKBA quarterly shareholders equity is now -95.40% below its all-time high of $635.93 million, reached on December 31, 2018.
Performance
AKBA quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AKBA Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.8% | +186.6% |
| 3 y3 years | -166.5% | -53.1% |
| 5 y5 years | -112.5% | -92.1% |
AKBA Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -166.5% | at low | -53.1% | +158.0% |
| 5 y | 5-year | -112.5% | at low | -92.1% | +158.0% |
| alltime | all time | -107.7% | at low | -95.4% | +123.0% |
AKBA Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $29.22M(+18.9%) |
| Mar 2025 | - | $24.58M(-150.0%) |
| Dec 2024 | -$49.19M(+60.8%) | -$49.19M(-2.4%) |
| Sep 2024 | - | -$50.40M(+49.3%) |
| Jun 2024 | - | -$33.75M(+23.8%) |
| Mar 2024 | - | -$27.26M(-10.9%) |
| Dec 2023 | -$30.58M(-684.8%) | -$30.58M(-22.4%) |
| Sep 2023 | - | -$39.42M(+47.1%) |
| Jun 2023 | - | -$26.81M(+86.8%) |
| Mar 2023 | - | -$14.35M(-374.4%) |
| Dec 2022 | $5.23M(-92.9%) | $5.23M(-62.2%) |
| Sep 2022 | - | $13.85M(-77.8%) |
| Jun 2022 | - | $62.30M(+138.6%) |
| Mar 2022 | - | $26.12M(-64.7%) |
| Dec 2021 | $74.01M(-70.1%) | $74.01M(-46.0%) |
| Sep 2021 | - | $137.15M(-21.5%) |
| Jun 2021 | - | $174.63M(-18.4%) |
| Mar 2021 | - | $213.89M(-13.6%) |
| Dec 2020 | $247.62M(-37.3%) | $247.62M(-22.1%) |
| Sep 2020 | - | $317.96M(-14.1%) |
| Jun 2020 | - | $370.26M(-6.6%) |
| Mar 2020 | - | $396.36M(+0.4%) |
| Dec 2019 | $394.76M | $394.76M(-15.6%) |
| Sep 2019 | - | $467.56M(-10.0%) |
| Jun 2019 | - | $519.36M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $566.38M(-10.9%) |
| Dec 2018 | $635.93M(+418.8%) | $635.93M(+346.1%) |
| Sep 2018 | - | $142.54M(-14.1%) |
| Jun 2018 | - | $165.92M(-15.8%) |
| Mar 2018 | - | $197.10M(+60.8%) |
| Dec 2017 | $122.57M(+79.9%) | $122.57M(+22.7%) |
| Sep 2017 | - | $99.88M(+75.2%) |
| Jun 2017 | - | $57.00M(+86.2%) |
| Mar 2017 | - | $30.62M(-55.1%) |
| Dec 2016 | $68.12M(-48.0%) | $68.12M(-32.4%) |
| Sep 2016 | - | $100.71M(-24.4%) |
| Jun 2016 | - | $133.29M(-20.5%) |
| Mar 2016 | - | $167.76M(+28.1%) |
| Dec 2015 | $131.00M(+25.9%) | $131.00M(-9.9%) |
| Sep 2015 | - | $145.41M(-2.9%) |
| Jun 2015 | - | $149.75M(+58.3%) |
| Mar 2015 | - | $94.61M(-9.1%) |
| Dec 2014 | $104.08M(+238.4%) | $104.08M(-8.4%) |
| Sep 2014 | - | $113.61M(-6.5%) |
| Jun 2014 | - | $121.55M(-4.9%) |
| Mar 2014 | - | $127.87M(-200.6%) |
| Dec 2013 | $30.76M(-1247.8%) | -$127.07M(+4642.4%) |
| Dec 2012 | -$2.68M(-149.7%) | - |
| Dec 2012 | - | -$2.68M |
| Dec 2011 | $5.39M | - |
FAQ
- What is Akebia Therapeutics, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Akebia Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of AKBA is -$49.19M
What is the all time high annual shareholders equity for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual stockholders equity is $635.93M
What is Akebia Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, AKBA annual stockholders equity has changed by -$18.60M (-60.82%)
What is Akebia Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of AKBA is $29.22M
What is the all time high quarterly shareholders equity for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly stockholders equity is $635.93M
What is Akebia Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, AKBA quarterly stockholders equity has changed by +$62.98M (+186.58%)